Shares of Calumet, Inc. (NASDAQ:CLMT – Get Free Report) have been assigned an average recommendation of “Hold” from the eight brokerages that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $24.00.
CLMT has been the subject of a number of recent research reports. TD Cowen boosted their price objective on shares of Calumet from $19.00 to $25.00 and gave the stock a “hold” rating in a research note on Thursday, March 5th. UBS Group reiterated a “neutral” rating and issued a $26.00 price target on shares of Calumet in a report on Friday, February 13th. Weiss Ratings reissued a “sell (d-)” rating on shares of Calumet in a research report on Monday, December 29th. The Goldman Sachs Group upped their price objective on Calumet from $20.00 to $24.00 and gave the stock a “buy” rating in a research note on Friday, January 30th. Finally, Wall Street Zen downgraded Calumet from a “buy” rating to a “hold” rating in a research report on Sunday, December 14th.
Check Out Our Latest Analysis on Calumet
Institutional Trading of Calumet
Calumet Stock Performance
NASDAQ CLMT opened at $28.85 on Wednesday. Calumet has a one year low of $7.68 and a one year high of $31.41. The company has a market capitalization of $2.50 billion, a price-to-earnings ratio of -73.97 and a beta of 1.18. The company’s 50-day simple moving average is $24.35 and its two-hundred day simple moving average is $20.73.
Calumet (NASDAQ:CLMT – Get Free Report) last announced its quarterly earnings results on Friday, February 27th. The oil and gas company reported ($0.43) earnings per share for the quarter, topping the consensus estimate of ($0.67) by $0.24. The business had revenue of ($3,098.50) million during the quarter, compared to analysts’ expectations of $1.04 billion. During the same period in the previous year, the company posted ($0.47) EPS. Calumet’s revenue for the quarter was up 9.4% on a year-over-year basis. Equities analysts expect that Calumet will post -3.02 earnings per share for the current fiscal year.
About Calumet
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
Read More
- Five stocks we like better than Calumet
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
